$36.90 -0.50 (-1.34%)
11/27/2009 1:01 PM

Eli Lilly & Co. (LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Results 1 - 20 of 145 1 2 3 4 5 6 7 8 Next »

Recs

0
Member Avatar 1ct (43.64) Submitted: 6/6/2007 2:16:22 PM : Outperform Start Price: $52.17 LLY Score: -5.52

worldwide distribution for diabetes and other diseases

Recs

0
Member Avatar 549549 (89.46) Submitted: 1/4/2007 11:57:53 AM : Outperform Start Price: $46.11 LLY Score: -2.39

big farma a bit undervalued, look for it to outpace the S&P this year

Recs

0
Member Avatar 82882 (51.80) Submitted: 11/17/2008 10:37:07 PM : Outperform Start Price: $31.12 LLY Score: -13.37

STABILLITY

Recs

0
Member Avatar abie1331 (45.76) Submitted: 1/27/2007 1:14:31 PM : Outperform Start Price: $46.52 LLY Score: -2.46

undervalued

Recs

0
Member Avatar advantage0407 (96.62) Submitted: 3/29/2007 1:48:59 PM : Outperform Start Price: $47.29 LLY Score: -3.75

Mega Drugs

Recs

0
Member Avatar agentscarn (21.45) Submitted: 3/11/2009 12:27:41 PM : Outperform Start Price: $27.97 LLY Score: -21.47

Medicine always in demand

Recs

0
Member Avatar albets (< 20) Submitted: 9/27/2007 9:29:01 AM : Outperform Start Price: $51.80 LLY Score: -3.84

Good product line with diabetes. Dibetes with obesity will be an epidemic

Recs

0
Member Avatar alfredomega (56.76) Submitted: 2/16/2009 8:42:36 PM : Outperform Start Price: $33.28 LLY Score: -28.23

bullish rsi

Recs

0
Member Avatar AllanYangMusic (< 20) Submitted: 4/21/2009 6:35:50 PM : Outperform Start Price: $31.73 LLY Score: -15.02

Eli Lily is one of the best and most consistently well managed companies. It understand the ebb and tides.

Recs

0
Member Avatar AW2580 (< 20) Submitted: 12/6/2007 11:22:14 AM : Outperform Start Price: $48.65 LLY Score: -1.02

potential buyout candidate

Recs

0
Member Avatar awallejr (79.38) Submitted: 10/2/2008 12:23:19 PM : Outperform Start Price: $40.44 LLY Score: -8.36

Aging/dividend

Recs

0
Member Avatar b6thadd9 (60.08) Submitted: 1/30/2007 11:57:24 AM : Outperform Start Price: $46.44 LLY Score: -2.10

Under priced for it's value

Recs

0
Member Avatar bartleyrc (69.51) Submitted: 3/29/2009 4:39:26 PM : Outperform Start Price: $30.70 LLY Score: -18.66

Over 11% annualized revenue growth over the last 5 years and a solid pipeline position LLY to outperform the S&P.

Recs

0
Member Avatar basilescu (96.93) Submitted: 2/6/2009 10:37:40 PM : Outperform Start Price: $35.95 LLY Score: -29.64

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases. Good diovidend too.

Recs

0
Member Avatar BIGDOGJII (64.92) Submitted: 3/1/2007 3:45:59 PM : Outperform Start Price: $46.24 LLY Score: -2.87

Div & Yield: 1.70 (3.20%)

Recs

0
Member Avatar BIGGUY11 (< 20) Submitted: 1/5/2008 8:13:07 AM : Outperform Start Price: $47.33 LLY Score: -2.56

Huge cash position and CIALIS. Sex sells and when you make a drug that improves a persons sex life, the sky is the limit.

Recs

0
Member Avatar bigi2u (94.54) Submitted: 11/2/2008 4:28:05 PM : Outperform Start Price: $32.13 LLY Score: -1.17

Dividend, dividend, dividend. And a Democratic congress and pres make this quite appealing.

Recs

0
Member Avatar BillyBeane (< 20) Submitted: 5/6/2008 1:53:05 AM : Underperform Start Price: $44.56 LLY Score: -1.70

expect to hit new lows

Recs

2
Member Avatar bobbyvee (98.27) Submitted: 3/7/2009 11:48:54 AM : Underperform Start Price: $26.58 LLY Score: +25.21

Pharaceuticals will suffer under this administration's plan for universal care

Recs

0
Member Avatar borgeron (< 20) Submitted: 12/8/2006 8:26:28 AM : Outperform Start Price: $47.31 LLY Score: -4.42

Drug in pipeline will drive earnings

Featured Broker Partners